Atea Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (AVIR)

Historical Holders from Q4 2020 to Q1 2025

Symbol
AVIR on Nasdaq
CUSIP
04683R106
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
84.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
56.2M
Holdings value
$188M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
103
Number of buys
44
Number of sells
-48
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Atea Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (AVIR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BML Investment Partners, L.P. 8.5% $24.3M 7.22M Leonard Braden Michael Dec 13, 2024
Radoff Bradley Louis 4% +10% $11.4M $820K 3.38M +8.86% Radoff Bradley Louis Apr 16, 2025
EcoR1 Capital, LLC 4% $11.3M 3.34M EcoR1 Capital, LLC Dec 31, 2024

Institutional Holders of Atea Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (AVIR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 154K $460K -$183K $2.92 4
2024 Q4 56.2M $188M -$6.77M $3.35 103
2024 Q3 57.9M $194M +$4.53M $3.35 105
2024 Q2 56.7M $188M +$7.27M $3.31 101
2024 Q1 54.3M $219M -$1.67M $4.04 110
2023 Q4 54.9M $167M -$2.06M $3.05 104
2023 Q3 56.8M $170M -$1.91M $3.00 115
2023 Q2 57M $213M +$726K $3.74 130
2023 Q1 56.8M $190M -$5.74M $3.35 127
2022 Q4 57.8M $278M -$5.11M $4.81 127
2022 Q3 56.9M $324M -$1.87M $5.69 111
2022 Q2 57.2M $405M +$19.3M $7.10 119
2022 Q1 52.4M $378M -$6.73M $7.22 116
2021 Q4 52.7M $471M -$416M $8.94 129
2021 Q3 56.8M $1.99B -$21.9M $35.06 138
2021 Q2 58.9M $1.27B +$154M $21.48 100
2021 Q1 49.4M $3.04B +$30.5M $61.75 80
2020 Q4 49.9M $2.07B +$1.82B $41.78 69